GEHealth Care将购买Intelerad为2.3B美元,以提升人工智能和云成像工具。 GE HealthCare to buy Intelerad for $2.3B to boost AI and cloud imaging tools.

GEHealth Care已同意以23亿美元现金购买设在芝加哥的一家医疗成像软件公司Intelerad,预期在2026年初完成,等待监管批准。 GE HealthCare has agreed to acquire Intelerad, a Chicago-based medical imaging software company, for $2.3 billion in cash, with completion expected in early 2026 pending regulatory approval. 该协议旨在扩大GE HealthCare的云型和AI驱动成像解决方案,特别是在门诊治疗方面,支持其到2028年将云型产品组合增加一倍的目标。 The deal aims to expand GE HealthCare’s cloud-based and AI-powered imaging solutions, especially in outpatient care, supporting its goal to triple its cloud-enabled product portfolio by 2028. 支持放射科和心脏病工作流程的Intelerad软件预计将产生2.70亿美元的年收入,其中90%是经常性的,有助于顶层增长,尽管短期内对收入稍有增加。 Intelerad’s software, which supports radiology and cardiology workflows, is expected to generate $270 million in annual revenue with 90% recurring and contribute to top-line growth, though it will be slightly dilutive to earnings in the short term. 购买是GE HealthCare战略的一部分,目的是通过综合技术加强其数字保健服务并改善成像工作流程。 The acquisition is part of GE HealthCare’s strategy to strengthen its digital health offerings and improve imaging workflows through integrated technology.